| pubmed-article:17208042 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C0019704 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C0030946 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C0017431 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C0013203 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C0939237 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C0002045 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C2347741 | lld:lifeskim |
| pubmed-article:17208042 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:17208042 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17208042 | pubmed:dateCreated | 2007-1-16 | lld:pubmed |
| pubmed-article:17208042 | pubmed:abstractText | Different approaches using genotypic, pharmacokinetic parameters or combination of both have been recently developed to monitor antiretroviral treatment in HIV-1-infected individuals. Their uses in clinical practice may improve the benefit of protease inhibitor-based salvage therapy while reducing treatment toxicity and emergence of viral resistance. | lld:pubmed |
| pubmed-article:17208042 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17208042 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17208042 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17208042 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17208042 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17208042 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17208042 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17208042 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17208042 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17208042 | pubmed:issn | 1386-6532 | lld:pubmed |
| pubmed-article:17208042 | pubmed:author | pubmed-author:MicheletChris... | lld:pubmed |
| pubmed-article:17208042 | pubmed:author | pubmed-author:RuffaultAnnic... | lld:pubmed |
| pubmed-article:17208042 | pubmed:author | pubmed-author:Bentué-Ferrer... | lld:pubmed |
| pubmed-article:17208042 | pubmed:author | pubmed-author:TattevinPierr... | lld:pubmed |
| pubmed-article:17208042 | pubmed:author | pubmed-author:ArvieuxCédric... | lld:pubmed |
| pubmed-article:17208042 | pubmed:author | pubmed-author:TributOlivier... | lld:pubmed |
| pubmed-article:17208042 | pubmed:author | pubmed-author:ChapplainJean... | lld:pubmed |
| pubmed-article:17208042 | pubmed:author | pubmed-author:MaillardAnneA | lld:pubmed |
| pubmed-article:17208042 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17208042 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:17208042 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17208042 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17208042 | pubmed:pagination | 131-8 | lld:pubmed |
| pubmed-article:17208042 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:meshHeading | pubmed-meshheading:17208042... | lld:pubmed |
| pubmed-article:17208042 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17208042 | pubmed:articleTitle | The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir-ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients. | lld:pubmed |
| pubmed-article:17208042 | pubmed:affiliation | Laboratoire de Virologie, Hôpital Pontchaillou, 2 rue Henri Le Guilloux, 35 033 Rennes, France. anne.maillard@chu-rennes.fr | lld:pubmed |
| pubmed-article:17208042 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17208042 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17208042 | lld:pubmed |
